Timothy P Kelly - Net Worth and Insider Trading
Timothy P Kelly Net Worth
The estimated net worth of Timothy P Kelly is at least $116 dollars as of 2024-06-02. Timothy P Kelly is the COO of Homology Medicines Inc and owns about 124 shares of Homology Medicines Inc (FIXX) stock worth over $116. Details can be seen in Timothy P Kelly's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Timothy P Kelly has not made any transactions after 2022-01-05 and currently still holds the listed stock(s).
Transaction Summary of Timothy P Kelly
Timothy P Kelly Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Timothy P Kelly owns 1 companies in total, including Homology Medicines Inc (FIXX) .
Click here to see the complete history of Timothy P Kelly’s form 4 insider trades.
Insider Ownership Summary of Timothy P Kelly
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| FIXX | Homology Medicines Inc | 2022-01-05 | See Remarks |
Timothy P Kelly Latest Holdings Summary
Timothy P Kelly currently owns a total of 1 stock. Timothy P Kelly owns 124 shares of Homology Medicines Inc (FIXX) as of January 5, 2022, with a value of $116.
Latest Holdings of Timothy P Kelly
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| FIXX | Homology Medicines Inc | 2022-01-05 | 124 | 0.93 | 116 |
Holding Weightings of Timothy P Kelly
Timothy P Kelly Form 4 Trading Tracker
According to the SEC Form 4 filings, Timothy P Kelly has made a total of 10 transactions in Homology Medicines Inc (FIXX) over the past 5 years, including 0 buys and 10 sells. The most-recent trade in Homology Medicines Inc is the sale of 78 shares on January 5, 2022, which brought Timothy P Kelly around $5,315.
Insider Trading History of Timothy P Kelly
- 1
Timothy P Kelly Trading Performance
Timothy P Kelly Ownership Network
Timothy P Kelly Owned Company Details
What does Homology Medicines Inc do?
Who are the key executives at Homology Medicines Inc?
Timothy P Kelly is the See Remarks of Homology Medicines Inc. Other key executives at Homology Medicines Inc include director & President & CEO Arthur Tzianabos , See Remarks Paul Alloway , and Chief Scientific Officer Albert Seymour .
Homology Medicines Inc (FIXX) Insider Trades Summary
Over the past 18 months, Timothy P Kelly made no insider transaction in Homology Medicines Inc (FIXX). Other recent insider transactions involving Homology Medicines Inc (FIXX) include a net sale of 21,335 shares made by Paul Alloway , a net sale of 23,653 shares made by Arthur Tzianabos , and a net sale of 5,068 shares made by Albert Seymour .
In summary, during the past 3 months, insiders sold 0 shares of Homology Medicines Inc (FIXX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 3,328 shares of Homology Medicines Inc (FIXX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 3,328 shares.
Homology Medicines Inc (FIXX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Homology Medicines Inc Insider Transactions
Timothy P Kelly Mailing Address
Above is the net worth, insider trading, and ownership report for Timothy P Kelly. You might contact Timothy P Kelly via mailing address: C/o Homology Medicines, Inc., One Patriots Park, Bedford Ma 01730.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
